Clinical trial
Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and…
NCT00325767 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00325767 |
|---|---|
| Title | Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol |
| Official title | Mucociliary Clearance in Healthy Subjects: Comparison of Levalbuterol and Racemic Albuterol |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Sumitomo Pharma America, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Mucociliary Clearance |
| Intervention type | Drug |
| Interventions | nebulized albuterol (2.5 mg/3ml/dose), nebulized levalbuterol (1.25 mg/3ml/dose), nebulized placebo (3ml/dose) |
| Enrollment | 10 |
| Start date | May 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | May 15, 2006 |
| Last update posted | May 15, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: